The thrombin generation test is one of the diagnostic tests currently in use as a universal method for measuring hemostatic disorders. We envisioned that conventional monitoring of thrombin generation could be miniaturized resulting in a time-saving, accurate, easy-to-operate, and cost-efficient test. For the translation of the conventional thrombin generation test to microfluidic devices, our focus was directed to parameters such as the detection limit, temperature, protein-surface interactions ͑i.e., hydrophilicity of microchannels͒, and mixing behavior. Scaling down to microchannels ͑e.g., capillaries͒ resulted in volume reduction and allowed us to study the effect of a microchannel surface ͑either hydrophilic or hydrophobic͒ on the thrombin activity. Finally, the use of a micromixer enabled us to perform efficient on-chip mixing, resulting in the successful measurement of a thrombin generation in a microfluidic device.
I. INTRODUCTION
Coronary heart disease, stroke and other cerebrovascular diseases, chronic obstructive pulmonary disease, HIV/AIDS, and lower respiratory infections are currently the primary causes of death worldwide. 1 With more than 22ϫ 10 6 fatalities annually, the demand for cheap, rapid, and reliable diagnostic tests for these diseases is ever increasing. 2 In particular, cardiac diagnostic tests have received significant attention as cardiovascular diseases cover nearly 60% of all mortalities. One of the diagnostic tests currently in use as a universal method for measuring hemostatic disorders is the thrombin generation test ͑TGT͒ developed by Giesen and co-workers. [3] [4] [5] This hemostatic disorders diagnostic tool, however, involves a highly complex, costly, and timeconsuming procedure that needs to be performed by a laboratory specialist. In contrast to conventional diagnostics, novel technology enabled by developments in microfluidics allows rapid diagnosis of blood or plasma samples at the patient's bed, the so-called point-of-care tests. 6, 7 Ideally, such tests can even be carried out by a patient himself enabling rapid diagnosis, which then facilitates the patient to adjust his medical treatment and monitor the development of his disease.
Since the introduction of microfluidic systems by Manz et al., 8 miniaturization of many chemical and biological processes has experienced a rapid growth. 9 As evidenced by the number of commercial applications described, application of microfluidic systems in a clinical environment has increased drastically. 10 Several restrictions such as the detection limit of the analytes, signal to noise ratio in the system, and/or photobleaching of the fluorescent samples, 11 however, still limit the number of diagnostic applications. Nevertheless, in the field of microfluidics a great interest exists for cardiac diagnostics. Schembri et al. 12 were the first to describe a whole blood multiple analyte analyzer using centrifugation and capillary forces. This centrifugal process for the extraction of plasma from sediment was later also used by Haeberle et al. 13 Other separation techniques applied were based on the bifurcation law 14 or interchannel microstructures. 15 Work by Song et al. 16 demonstrated that clotting times of whole blood and plasma could be determined in very small volumes using a plug-based microfluidic system. Elaborating on the results of Hemker et al., 5 we envisioned that conventional monitoring of thrombin generation could also be miniaturized resulting in a time-saving, accurate, easy-tooperate, and cost-efficient test. More importantly, lab-on-achip technology enables the use of a diversity of reagents for simultaneous determination of different clotting factors integrating multiple diagnostic tests onto one microchip. Automation of the whole sequence of handling will result in a more robust and reliable system that is less error prone as compared to the conventional test. In this contribution we report the first example of a miniaturized thrombin generation test on a chip.
II. EXPERIMENTAL DETAILS

A. Equipment
Fluorescence microscopy was performed on a Zeiss Axiovert 135 TV with a 10ϫ / 0.50 objective equipped with a DAPI-Aniline blue filter, ex 385 nm. Images were recorded by a Photometrics Coolsnap Camera with a shutter speed of 12 s. As a 96-wells plate fluorometer a Multicounter Wallac Victor2 ͑equipped with an Umbelliferone filter͒, ex 385 nm, T = 25°C was used. The setup that was used to perform the TGT in a microreactor is schematically depicted in Fig. 1͑a͒ . A commercially available microreactor ͑type TD18, internal volume 3.8 l͒ was purchased from Micronit Microfluidics BV ͑Enschede, The Netherlands͒. All syringes ͑Harvard apparatus; high pressure syringe, 2.5 ml͒ mounted on a syringe a͒ Authors to whom correspondence should be addressed. Electronic addresses: j.vanhest@science.ru.nl and f.rutjes@science.ru.nl. pump ͑New Era; type NE-1000͒ were connected using Swagelok connections to FEP tubing ͑Upchurch Scientific; type: 1529L 1 / 16Љ OD, 1 / 100Љ ID͒. At the end of each tubing, a special flat "bottom headless nut" ͑Upchurch Scientific; type: M-660͒ was introduced, which pressed down onto a special flat bottom ferrule ͑Upchurch Scientific; type: M-650͒ to achieve a gas tight fluid connection to the microreactor. The microreactor was positioned in a chipholder ͑custom built͒ 17 with threaded holes on the top side in which the nuts were screwed. The chipholder was positioned onto the fluorescence microscope during the measurements.
B. Materials
Fluorogenic substrate Cbz-Gly-Gly-Arg-AMC ͑I-1140͒ was obtained from Bachem A.G. ͑Bubendorf, Switzerland͒. A solution referred to as Fluo contained 7.5 l of a 100 mM solution of Cbz-Gly-Gly-Arg-AMC in dimethylsulfoxide ͑DMSO͒ and 292.5 l buffer ͑Hepes 20 mM, pH 7.35, containing 60 g/l BSA ͑bovine serum albumin, Sigma, A-7030͒, referred to as BSA60͒. A solution referred to as FluCa contained 25 l of a 100 mM solution of Cbz-Gly-Gly-Arg-AMC in DMSO, 875 l buffer ͑BSA60͒ and 100 l 1M CaCl 2 , resulting in a concentration of 2.5 mM in fluorogenic substrate and 100 mM in CaCl 2 . Platelet poor plasma ͑PPP͒ was prepared according to literature 5 and stored at −80°C. Prior to use the sample was allowed to warm to room temperature. A solution referred to as TF/PL consisted of 30 pM relipidated Tissue Factor ͑Innovin®, Dade Behring, Marburg, Germany͒ and 24 M phospholipids in Hepesbuffered saline, prepared according to literature. 18 All other reagents were used as purchased.
Hydrophilic fused silica capillaries with a polyimide coating were obtained from PolyMicro ͑Eerbeek, The Neth-erlands͒ with an inner diameter of 100 m, outer diameter of 365 m, and a length of 30 cm ͑total internal volume 2.4 l͒.
C. Methods
A transparent detection window in the capillaries ͑typically 2-3 cm in length͒ was created by removing the coating by applying a short ͑typically 1-2 s͒ external heat source ͑typically a flame͒. The soot formed was easily removed from the capillary by a wet tissue leaving the detection window.
To construct a hydrophobic capillary, a solution of 10 l ODS-Cl ͑octadecyltrichlorosilane͒ dissolved in 1 ml of toluene was pumped through the capillary. The solution in the capillary was left for 15-20 min. Subsequently, approximately 2 ml of toluene ͑1 ml min −1 ͒ was pumped through. Finally, approximately 2 ml of acetone was pumped through ͑1 ml min −1 ͒ and the capillary was dried with pressurized dry air.
Conventional TGT in a 96-wells plate was carried out using the following procedure. The sample ͑PPP͒ was allowed to warm to room temperature prior to use. 80 l Sample ͑PPP͒, 20 l TF/PL solution and 20 l FluCa were added to four wells in a 96-wells titer plate and mixed for 10 s ͑t =0͒. The titer plate was placed in the 96-wells plate fluorometer. The temperature was set to 25°C and the fluorescence measurement was started ͑measuring every 15 s for 40 min͒.
TGT in capillaries was performed using 40 l of sample ͑PPP͒, which was premixed with 10 l FluCa in order to initiate the test ͑t =0͒. Subsequently, the mixed solution was brought into the capillary by applying reduced pressure and the fluorescence was measured by fluorescence microscopy.
Mixing experiments in the micromixer were performed by filling syringe I with Rhodamine B solution ͑1 mg/ml in de-ionized water͒ and syringe II with de-ionized water. Both syringes were mounted on the syringe pumps and connected to the microchip. Pump I was programmed to deliver 50 l at a pump rate of 450 l min −1 . Pump II was programmed to deliver 25 l at a pump rate of 225 l min −1 . The microchip was positioned on the microscope ͑Zeiss, Axiovert 40 MAT͒ and the mixing experiment was initiated by starting both pumps at exactly the same time. Images were recorded with a digital camera ͑Carl Zeiss, Axiocam MRc5͒.
TGT in a micromixer was carried out by filling syringe I with sample ͑PPP, typically 300 l͒ and syringe II with re- agent ͑typically 150 l TF/PL solution and 150 l FluCa͒. 19 Both syringes were mounted on the syringe pumps and connected to the microreactor. Pump I was programmed to deliver 50 l at a pump rate of 450 l min −1 . Pump II was programmed to deliver 25 l at a pump rate of 225 l min −1 . To initiate the reaction, both pumps were started exactly at the same time, and the fluorescence in the microreactor was measured for 40 min by fluorescence microscopy.
III. RESULTS AND DISCUSSION
For reliable miniaturization of the conventional thrombin generation test several parameters such as temperature, detection limit, protein-surface interactions, and mixing behavior required profound investigation. Temperature plays an important role in many biological processes including thrombin generation. Preferably enzymatic reactions are carried out at 37°C. However, our microfluidic device was designed to function at ambient temperature. As a point of reference the conventional thrombin generation test therefore first needed to be performed in a 96-wells plate ͓Fig. 1͑a͔͒ at 25°C instead of the usual 37°C.
Miniaturization of the 96-wells plate to capillaries ͓Fig. 1͑b͔͒ will result in sample volume reduction and efficient and reliable detection becomes an issue to address. In the conventional test the fluorophore ͑7-amino-4-methyl-coumarin, AMC͒ is liberated and measured using a standard 96-wells plate fluorometer. In the miniaturized setup ͓Fig. 1͑b͔͒ fluorescence microscopy was used in order to detect the fluorescent signal, and the efficiency of this method had to be determined. The use of microchannels for the TGT results in a diagnostic device with an increased surface to volume ratio when compared to the conventional test. The effect of the hydrophilicity of the channel walls therefore also had to be taken into consideration as protein-surface interactions affect coagulation behavior. Finally, in order to obtain an efficient mixing procedure of the sample and diagnostic fluid, we investigated the use of a micromixer ͓Fig. 1͑c͔͒.
Performing the thrombin generation test in a 96-wells plate at 25°C resulted in a fluorescence trace as a function of time as depicted in Fig. 2͑a͒ . The thrombin activity rapidly decreases in plasma as a result of plasma inhibitors. The most important of these inhibitors, ␣ 2 -macroglobulin, encap-sulates thrombin, forming a ͑␣ 2 -M-T͒ complex. This ␣ 2 -M-T complex switches off all biological activity of thrombin ͑i.e., coagulation initiation͒ except for the amidolytic action on small substrates. 20 Consequently, there is continuous hydrolysis of fluorescent substrate ͑Cbz-Gly-Gly-Arg-AMC͒ due to the presence of the ␣ 2 -M-T complex, giving rise to an increased fluorescence signal. Thus the thrombin generation curve ͑or thrombogram͒ is comprised of the fluorescent signal produced by free thrombin and the complex of thrombin with ␣ 2 -macroglobulin. Mathematical processing 21 was applied to convert the fluorescent signal into free thrombin activity by subtracting the ␣ 2 M-T activity, generating Fig.  2͑b͒ . 22 The results shown in Fig. 2 demonstrate that performing the TGT at a lower temperature provided comparable thrombograms, although the time-to-peak was significantly prolonged. It could however be concluded that no intrinsic problems were encountered by performing the test at ambient temperature.
The conventional TGT consumes 80 l of sample and 40 l of reagents per test, which can easily be reduced upon usage of capillaries or other microfluidic systems. In the first miniaturized experiments, the sample and reagents were premixed outside a microchannel, after which the mixture was introduced into a capillary by reduced pressure and the thrombin generation was measured ͓schematically depicted in Fig. 1͑b͔͒ . Initially, we tested the TGT in fused silica capillaries with an inner diameter of 100 m ͑total internal volume 2.4 l͒. To investigate the effect of the polarity of the surface, both hydrophobic and hydrophilic capillaries were examined at 25°C ͑Fig. 3͒.
The hydrophobicity has a significant effect on the time to peak, as shown in Fig. 3 . Using a hydrophobic channel resulted in a delay of the time to peak of approximately 13 min in comparison with the hydrophilic channel ͑17.8 and 4.7 min., respectively͒. This could be explained by the enhanced binding of proteins to the hydrophilic surface of the capillary hence increasing the coagulation activity via the intrinsic pathway ͑i.e., coagulation in a blood vessel initiated by the activation by certain negatively charged surfaces 23 ͒. Comparing the results of both capillaries with the established 96wells plate results, the hydrophobic capillary yielded the more similar outcome, with no significant difference in the time-to-peak parameter ͑17.8 and 15.8 min, respectively͒. To demonstrate that thrombin generation could also be measured in a microchip ͓using a commercially available micromixer, as depicted in Fig. 1͑c͔͒ , we initially applied the premixing method as described for the capillaries prior to injection into the microchip. The fluorescence signal was monitored during 40 min and after mathematical processing, 21 the thrombogram was generated ͑Fig. 4͒.
The obtained thrombogram ͑Fig. 4͒ demonstrates that the thrombin generation can be monitored in the micromixer. Remarkably, the time to peak ͑13.2 min͒ was situated in between the times found for the hydrophobic and hydrophilic fused silica capillaries while the material of the microchip is hydrophilic ͑untreated borosilicate glass͒. The increased time to peak might be explained by the slightly different composition of the channel material and the lower surface-tovolume ratio of the microchip compared to the capillary which could decrease the intrinsic coagulation activation.
Encouraged by these results, we investigated the possibility to eliminate the premixing step by applying an excellent micromixer chip. 24, 25 To evaluate the mixing behavior of this micromixer, two aqueous solutions ͑one containing the fluorescent dye Rhodamine B, the other de-ionized water͒ were pumped at a controlled rate through the micromixer. Figure 5 shows that after four mixing units mixing was complete. By replacing the aqueous solution with a BSA buffer solution ͑closer related to physiological conditions͒, similar mixing behavior was observed. 21 Having established that the mixing in a micromixer occurs rapidly, we proceeded by performing the TGT in this specific micromixer. The premixing step was eliminated by introducing the sample and reagent via separate syringes into the microchip, as depicted in Fig. 1͑c͒ . The pump rate for the two solutions was set at a ratio of 2:1 ͑sample:reagents͒. After loading the microchip with the appropriate amount of sample and reagent ͑approximately 4 l͒ thrombin generation was monitored during a period of 40 min. To our satisfaction we obtained the thrombogram, as depicted in Fig. 6 .
Comparing the on-chip mixing procedure with the premix method, modest variations in time to peak and peak height were observed. The distribution is slightly broadened indicating a delayed and prolonged thrombin generation. This can possibly be explained by the low accessibility of TF, which could be improved by changing the mixing ratio. 26 Based on these results it can thus be concluded that the TGT can be performed in a micromixer with efficient on-chip mixing, lower sample volumes, and excellent detection. 
IV. CONCLUDING REMARKS
The focus of our research was to investigate the miniaturization of the conventional thrombin generation test by applying microfluidic devices. We demonstrated that thrombin generation can be measured in different microfluidic devices with excellent detection. The use of microfluidics resulted in 30-fold sample volume reduction. The influence of protein-surface interaction was demonstrated using both hydrophilic and hydrophobic capillaries resulting in a large shift in time to peak possibly as a result of contact activation of the intrinsic coagulation pathway by the glass surface. The use of a micromixer enabled us to perform efficient on-chip mixing, which resulted in the successful measurement of a thrombin generation curve. With this work we demonstrated that microreactor technology is suitable for miniaturization of the conventional thrombin generation test. As a next step validation of this test by calibrating the fluorescent signal and performing the TGT in a hydrophobic micromixer will be examined.
